Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Aldosterone is a major mineralocorticoid hormone that plays a key role in the regulation of electrolyte balance and blood pressure. Excess aldosterone levels can arise from dysregulation of the renin-angiotensin-aldosterone system and are implicated in the pathogenesis of hypertension and heart failure. Aldosterone synthase (cytochrome P450 11B2, CYP11B2) is the sole enzyme responsible for the production of aldosterone in humans. Blocking of aldosterone synthesis by mediating aldosterone synthase activity is thus a recently emerging pharmacological therapy for hypertension, yet a lack of structural information has limited this approach. Here, we present the crystal structures of human aldosterone synthase in complex with a substrate deoxycorticosterone and an inhibitor fadrozole. The structures reveal a hydrophobic cavity with specific features associated with corticosteroid recognition. The substrate binding mode, along with biochemical data, explains the high 11β-hydroxylase activity of aldosterone synthase toward both gluco- and mineralocorticoid formation. The low processivity of aldosterone synthase with a high extent of intermediates release might be one of the mechanisms of controlled aldosterone production from deoxycorticosterone. Although the active site pocket is lined by identical residues between CYP11B isoforms, most of the divergent residues that confer additional 18-oxidase activity of aldosterone synthase are located in the I-helix (vicinity of the O(2) activation path) and loops around the H-helix (affecting an egress channel closure required for retaining intermediates in the active site). This intrinsic flexibility is also reflected in isoform-selective inhibitor binding. Fadrozole binds to aldosterone synthase in the R-configuration, using part of the active site cavity pointing toward the egress channel. The structural organization of aldosterone synthase provides critical insights into the molecular mechanism of catalysis and enables rational design of more specific antihypertensive agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Mammalian Microsomal Cytochrome P450 Monooxygenase
Williams, P. A., Cosme, J., Sridhar, V., Johnson, E. F., & McRee, D. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80408-6 · Cited by 696
Structural basis for androgen specificity and oestrogen synthesis in human aromatase
Ghosh, D., Griswold, J., Erman, M., & Pangborn, W. (2009) · Nature · doi:10.1038/nature07614 · Cited by 618 · cited 1×
“In fact, the distance is the same as in aromatase (CYP19A1) in complex with androstenedione (33).”
The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex
Curnow, K. M., Tusie-Luna, M.-T., Pascoe, L., Natarajan, R., Gu, J.-L., Nadler, J. L., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1513 · Cited by 362
Acute and chronic regulation of aldosterone production
Hattangady, N. G., Olala, L. O., Bollag, W. B., & Rainey, W. E. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.034 · Cited by 347 · cited 1×
“Aldosterone synthesis is regulated by angiotensin II and potassium levels, as well as ACTH, in an acute or chronic manner (13).”
Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system
Strushkevich, N., MacKenzie, F., Cherkesova, T., Grabovec, I., Usanov, S., & Park, H.-W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019441108 · Cited by 337 · cited 3×
“Human CYP17A1, CYP19A1, CYP21A2, adrenodoxin (Adx), Adx reductase, and rat NADPH-cytochrome P450 reductase were purified as described (19, 20).”
Self-citationPascoe, L., Curnow, K. M., Slutsker, L., Connell, J. M., Speiser, P. W., New, M. I., & White, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8327 · Cited by 271 · cited 1×
“Studies of the chimeric enzymes, encoded by genes with CYP11B1 sequence at 5 and CYP11B2 sequence at 3 end and found in patients with glucocorticoid-remediable aldosteronism (GRA) (45, 46), have led to the conclusion that residues encoded by exon 5 and downstream exons of CYP11B2 are critical for aldosterone productio…”
Kawamoto, T., Mitsuuchi, Y., Toda, K., Yokoyama, Y., Miyahara, K., Miura, S., Ohnishi, T., Ichikawa, Y., Nakao, K., & Imura, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1458 · Cited by 245
The regulation of 17,20 lyase activity
Miller, W. L., Auchus, R. J., & Geller, D. H. (1997) · Steroids · doi:10.1016/s0039-128x(96)00172-9 · Cited by 227 · cited 1×
“It might be similar as observed for CYP17A1, where its lyase activity is regulated by cytochrome b5 (43, 44).”
Pascoe, L., Curnow, K. M., Slutsker, L., Rösler, A., & White, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4996 · Cited by 188
Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism
Kawamoto, T., Mitsuuchi, Y., Ohnishi, T., Ichikawa, Y., Yokoyama, Y., Sumimoto, H., Toda, K., Miyahara, K., Kuribayashi, I., Nakao, K., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81058-7 · Cited by 152 · cited 1×
“1) Measured reflections 1,041,277 (137,486) 678,165 (85,684) Unique reflections 245,749 (34,366) 188,505 (26,406) Redundancy 4.”
Curnow, K. M., Mulatero, P., Emeric-Blanchouin, N., Aupetit-Faisant, B., Corvol, P., & Pascoe, L. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0197-32 · Cited by 102
Mitsuuchi, Y., Kawamoto, T., Miyahara, K., Ulick, S., Morton, D. H., Naiki, Y., Kuribayashi, I., Toda, K., Hara, T., Orii, T., et al. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1128 · Cited by 93
Mulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88
Böttner, B., Denner, K., & Bernhardt, R. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520458.x · Cited by 62
Cited by
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Tebben, P. J., Singh, R. J., & Kumar, R. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1070 · Cited by 442
Regulation of aldosterone synthesis and secretion.
Bollag, W. B. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130037 · Cited by 180
Rege, J., Turcu, A., Kasa-Vubu, J. Z., Lerario, A. M., Auchus, G. C., Auchus, R. J., Smith, J. M., White, P. C., & Rainey, W. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00736 · Cited by 154
Clinical significance of 11-oxygenated androgens
Turcu, A. F., & Auchus, R. J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000334 · Cited by 80
Johnston, Z. C., Bellingham, M., Filis, P., Soffientini, U., Hough, D., Bhattacharya, S., Simard, M., Hammond, G. L., King, P., O’Shaughnessy, P. J., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1009-7 · Cited by 44
Metadata
- Authors
- Strushkevich, N., Gilep, A. A., Shen, L., Arrowsmith, C. H., Edwards, A. M., Usanov, S. A., & Park, H.-W.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2013-02-01
- Volume
- 27
- Issue
- 2
- Pages
- 315-324
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2138101271
- Cited by
- 135
- References
- 15
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.